These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 808204)

  • 1. Survival after regional perfusion for limb melanoma.
    Cox KR
    Aust N Z J Surg; 1975 Feb; 45(1):32-6. PubMed ID: 808204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional chemotherapy for melanoma. A 35-year experience.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
    Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 4. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion of melanoma. 105 isolated perfusions in 92 patients.
    Golomb FM
    Oncology; 1972; 26(2):197-205. PubMed ID: 4626136
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
    McBride CM; Sugarbaker EV; Hickey RC
    Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
    Alrich EM; Manwaring JL; Horsley JS
    Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
    Krementz ET; Ryan RF
    Ann Surg; 1972 Jun; 175(6):900-17. PubMed ID: 4625027
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
    Ariyan S; Poo WJ; Bolognia J
    Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study.
    Guadagni S; Santinami M; Patuzzo R; Pilati PL; Miotto D; Deraco M; Rossi CR; Fiorentini G; Di Filippo F; Valenti M; Amicucci G
    Melanoma Res; 2003 Feb; 13(1):51-8. PubMed ID: 12569285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
    Bulman AS; Jamieson CW
    Br J Surg; 1980 Sep; 67(9):660-2. PubMed ID: 7427069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.
    Deroose JP; Grünhagen DJ; van Geel AN; de Wilt JH; Eggermont AM; Verhoef C
    Br J Surg; 2011 Nov; 98(11):1573-80. PubMed ID: 21739427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional chemotherapy--perfusion of the extremities].
    Meyer T; Göhl J
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion of melanoma. 133 isolated perfusions in 114 patients.
    Golomb FM
    Panminerva Med; 1976; 18(1-2):8-10. PubMed ID: 813172
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.
    Sugarbaker EV; McBride CM
    Cancer; 1976 Jan; 37(1):188-98. PubMed ID: 1247954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
    Hansson JA; Simert G; Vang J
    Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
    Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
    J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs.
    Thompson JF; Gianoutsos MP
    World J Surg; 1992; 16(2):227-33. PubMed ID: 1561803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of treatment results of melanoblastoma of the limbs with or without perfusion chemotherapy].
    Levin AO; Stepanova NS; Chikinda IuN
    Vestn Khir Im I I Grek; 1979 Feb; 122(2):53-6. PubMed ID: 108833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.